Search Results

This report presents results from the Mental Health Client-Level Data (MH-CLD) and Mental Health Treatment Episode Data Set (MH-TEDS) for individuals receiving mental health services from state mental health systems in 2018, as well as selected trends in data collected from such individuals between 2013 and 2018. The report provides...

This report presents results from the Mental Health Client-Level Data (MH-CLD) and Mental Health Treatment Episode Data Set (MH-TEDS) for individuals receiving mental health services from state mental health systems in 2017, as well as selected trends in data collected from such individuals between 2014 and 2017. The report provides...

This report presents results from the Mental Health Client Level Data (MH-CLD) and Mental Health Treatment Episode Data Set (MH-TEDS) for individuals receiving mental health treatment services in 2016, as well as selected trends in data collected from such individuals between 2013 and 2016. The report provides information on mental...

This report presents results from the Mental Health Client-Level Data (MH-CLD) and Mental Health Treatment Episode Data Set (MH-TEDS) for individuals receiving mental health treatment services in 2015, as well as selected data collection trends for such individuals from 2012 to 2015. The report provides information on mental health diagnoses...

This Drug Abuse Warning Network (DAWN) short report shows the estimated number of emergency room visits involving buprenorphine between 2005 and 2011. Buprenorphine is used to treat dependence on heroin and narcotic pain medications. The report also shows buprenorphine-related visits broken out by non-medical use, adverse reactions and seeking detoxification...

This Drug Abuse Warning Network (DAWN) report shows emergency room visits in 2010 involving synthetic cannabinoid products commonly called \"Spice\" or \"K2\". These drugs are also known as synthetic marijuana,

This Drug Abuse Warning Network (DAWN) short report shows the estimated number of emergency department visits involving phencyclidine (PCP) between 2005 and 2011. The report specifically talks about age groups, gender and other drugs such as marijuana, cocaine, heroin and pharmaceuticals and trends over time.